Home » “Clinical Criteria and Prescription Guidelines for Reimbursable Janus Kinase Inhibitors in Italy: A Study on Italian Medicines Agency Restrictions”

“Clinical Criteria and Prescription Guidelines for Reimbursable Janus Kinase Inhibitors in Italy: A Study on Italian Medicines Agency Restrictions”

by satcit

https://pubmed.ncbi.nlm.nih.gov/38115771

This study discusses the clinical criteria and prescription guidelines for reimbursable Janus kinase inhibitors in Italy, following restrictions set by the Italian Medicines Agency.

You may also like

Leave a Comment